| 原料品名 | prucalopride succinate |
|---|---|
| 原料中文名称 | 琥珀酸普芦卡必利 |
| 中文别名 | 普卢卡必利琥珀酸盐;普芦卡必利杂质;RESOLOR;R-108512;普卡比利琥珀酸盐;琥珀酸普卡必利,一种5-HT4 受体选择高亲和性激动剂;琥珀酸普鲁卡匹利;丁二酸 4-氨基-5-氯-2,3-二氢-N-[1-(3-甲氧基丙基)-4-哌啶基]-7-苯并呋喃甲酰胺;琥珀酸普卡必利 |
| 化学名称 | 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;butanedioic acid |
| 分子式 | C22H32ClN3O7 |
| 分子量 | 485.95 |
| CAS号 | 179474-85-2 |
| 结构式图片 | 暂无权限 |
供应商信息
| 企业名称 | Shilpa Medicare Ltd |
|---|---|
| 企业类型 | 生产商 |
| 地址 | Shilpa House,Hyderabad Road, Raichur – 584 135 ,Karnataka,India |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 联系人 | 暂无权限 |
| 公司资质 | 暂无权限 |
| 公司简介 | Manufacturing started in 1989, Shilpa Medicare is a fully integrated pharmaceutical company, present across the entire pharmaceutical value chain from Research and Development, Active Pharmaceutical Ingredients, Finished Formulations, Biologicals, ODF and Nano Science and Nano Technology etc.State–of–the–art manufacturing facilities approved by USFDA, AGES-Austria, PMDA, Cofepris-Mexico, etc.,2 R&D Centres with capabilities of ANDAs, DMFs and NDDS.Qualified, experienced and trained staff to handle respective functions.Over 357 patents filed by Shilpa & its entities includes drug substances, products and polymorphs. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
